Tower Research Capital LLC (Trc) Rezolute, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.39 Billion
- Q3 2025
A detailed history of Tower Research Capital LLC (Trc) transactions in Rezolute, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,469 shares of RZLT stock, worth $24,467. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,469
Previous 3,048
19.0%
Holding current value
$24,467
Previous $13,000
69.23%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RZLT
# of Institutions
123Shares Held
68.9MCall Options Held
1.01MPut Options Held
57.2K-
Federated Hermes, Inc. Pittsburgh, PA14MShares$139 Million0.25% of portfolio
-
Siren, L.L.C. New York, NY4.87MShares$48.3 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$43.7 Million0.0% of portfolio
-
Blackstone Inc New York, NY3.02MShares$30 Million0.13% of portfolio
-
Mangrove Partners New York, NY2.88MShares$28.6 Million3.44% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $385M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...